{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:53:01Z","timestamp":1792882381235,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074054"],"award-info":[{"award-number":["82074054"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Trans-cinnamaldehyde (TCA) is one of the main pharmaceutical ingredients of <jats:italic>Cinnamomum cassia Presl<\/jats:italic>, which has been shown to have therapeutic effects on a variety of cardiovascular diseases. This study was carried out to characterize and reveal the underlying mechanisms of the protective effects of TCA against cardiac hypertrophy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used phenylephrine (PE) to induce cardiac hypertrophy and treated  with TCA in vivo and in vitro. In neonatal rat cardiomyocytes (NRCMs), RNA sequencing and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were carried out to identify potential pathways of TCA. Then, the phosphorylation and nuclear localization of calcium\/calmodulin-dependent protein kinase II (CaMKII) and extracellular signal-related kinase (ERK) were detected. In adult mouse cardiomyocytes (AMCMs), calcium transients, calcium sparks, sarcomere shortening and the phosphorylation of several key proteins for calcium handling were evaluated. For mouse in vivo experiments, cardiac hypertrophy was evaluated by assessing morphological changes, echocardiographic parameters, and the expression of hypertrophic genes and proteins.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>TCA suppressed PE-induced cardiac hypertrophy and the phosphorylation and nuclear localization of CaMKII and ERK in NRCMs. Our data also demonstrate that TCA blocked the hyperphosphorylation of ryanodine receptor type 2 (RyR2) and phospholamban (PLN) and restored Ca<jats:sup>2+<\/jats:sup> handling and sarcomere shortening in AMCMs. Moreover, our data revealed that TCA alleviated PE-induced cardiac hypertrophy in adult mice and downregulated the phosphorylation of CaMKII and ERK.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>TCA has a protective effect against PE-induced cardiac hypertrophy that may be associated with the inhibition of the CaMKII\/ERK pathway.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-022-03594-1","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T13:05:13Z","timestamp":1650891913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Trans-cinnamaldehyde protects against phenylephrine-induced cardiomyocyte hypertrophy through the CaMKII\/ERK pathway"],"prefix":"10.1186","volume":"22","author":[{"given":"Dongdong","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sining","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"key":"3594_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","volume":"65","author":"N Frey","year":"2003","unstructured":"Frey N, Olson E. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol. 2003;65:45\u201379.","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"3594_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/ejhf.705","volume":"19","author":"H Sabbah","year":"2017","unstructured":"Sabbah H. Silent disease progression in clinically stable heart failure. Eur J Heart Fail. 2017;19(4):469\u201378.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"3594_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s12471-016-0943-2","volume":"25","author":"M Michels","year":"2017","unstructured":"Michels M, Olivotto I, Asselbergs F, van der Velden J. Life-long tailoring of management for patients with hypertrophic cardiomyopathy : awareness and decision-making in changing scenarios. Neth Hear J. 2017;25(3):186\u201399.","journal-title":"Neth Hear J"},{"key":"3594_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.644630","volume":"9","author":"J Duran","year":"2021","unstructured":"Duran J, Nickel L, Estrada M, Backs J, van den Hoogenhof M. CaMKII\u03b4 splice variants in the healthy and diseased heart. Front Cell Dev Biol. 2021;9:644630.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"3594_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.cardiores.2006.11.005","volume":"73","author":"L Maier","year":"2007","unstructured":"Maier L, Bers D. Role of Ca2+\/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. Cardiovasc Res. 2007;73(4):631\u201340.","journal-title":"Cardiovasc Res"},{"issue":"9","key":"3594_CR6","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1161\/CIRCRESAHA.120.316947","volume":"127","author":"S Ljubojevic-Holzer","year":"2020","unstructured":"Ljubojevic-Holzer S, Herren A, Djalinac N, Voglhuber J, Morotti S, Holzer M, et al. CaMKII\u03b4C drives early adaptive Ca change and late eccentric cardiac hypertrophy. Circ Res. 2020;127(9):1159\u201378.","journal-title":"Circ Res"},{"issue":"4","key":"3594_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00395-018-0688-8","volume":"113","author":"J Beckendorf","year":"2018","unstructured":"Beckendorf J, van den Hoogenhof M, Backs J. Physiological and unappreciated roles of CaMKII in the heart. Basic Res Cardiol. 2018;113(4):29.","journal-title":"Basic Res Cardiol"},{"issue":"8","key":"3594_CR8","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1517\/14728222.2013.809064","volume":"17","author":"B Westenbrink","year":"2013","unstructured":"Westenbrink B, Edwards A, McCulloch A, Brown J. The promise of CaMKII inhibition for heart disease: preventing heart failure and arrhythmias. Expert Opin Ther Targets. 2013;17(8):889\u2013903.","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"3594_CR9","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.yjmcc.2011.01.012","volume":"51","author":"M Anderson","year":"2011","unstructured":"Anderson M, Brown J, Bers D. CaMKII in myocardial hypertrophy and heart failure. J Mol Cell Cardiol. 2011;51(4):468\u201373.","journal-title":"J Mol Cell Cardiol"},{"key":"3594_CR10","doi-asserted-by":"crossref","unstructured":"Gilbert C, Longenecker J, Accornero F. ERK1\/2: an integrator of signals that alters cardiac homeostasis and growth. Biology(Basel). 2021;10(4):346.","DOI":"10.3390\/biology10040346"},{"key":"3594_CR11","volume-title":"Multiple sources of signal amplification within the B cell Ras\/MAPK pathway","author":"MJD WOD","year":"2018","unstructured":"WOD MJD. Multiple sources of signal amplification within the B cell Ras\/MAPK pathway; 2018."},{"issue":"14","key":"3594_CR12","doi-asserted-by":"publisher","first-page":"11725","DOI":"10.18632\/oncotarget.3955","volume":"6","author":"Y Wang","year":"2015","unstructured":"Wang Y, Zhao R, Zhe H. The emerging role of CaMKII in cancer. Oncotarget. 2015;6(14):11725\u201334.","journal-title":"Oncotarget"},{"issue":"46","key":"3594_CR13","doi-asserted-by":"publisher","first-page":"45101","DOI":"10.1074\/jbc.M305355200","volume":"278","author":"M Illario","year":"2003","unstructured":"Illario M, Cavallo A, Bayer K, Di Matola T, Fenzi G, Rossi G, et al. Calcium\/calmodulin-dependent protein kinase II binds to Raf-1 and modulates integrin-stimulated ERK activation. J Biol Chem. 2003;278(46):45101\u20138.","journal-title":"J Biol Chem"},{"issue":"6","key":"3594_CR14","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1210\/en.2009-1248","volume":"151","author":"E Cipolletta","year":"2010","unstructured":"Cipolletta E, Monaco S, Maione A, Vitiello L, Campiglia P, Pastore L, et al. Calmodulin-dependent kinase II mediates vascular smooth muscle cell proliferation and is potentiated by extracellular signal regulated kinase. Endocrinology. 2010;151(6):2747\u201359.","journal-title":"Endocrinology"},{"issue":"6","key":"3594_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130477","volume":"10","author":"E Cipolletta","year":"2015","unstructured":"Cipolletta E, Rusciano M, Maione A, Santulli G, Sorriento D, Del Giudice C, et al. Targeting the CaMKII\/ERK interaction in the heart prevents cardiac hypertrophy. PLoS One. 2015;10(6):e0130477.","journal-title":"PLoS One"},{"issue":"1","key":"3594_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1755-5922.2008.00068.x","volume":"27","author":"Y Lu","year":"2009","unstructured":"Lu Y, Shioda N, Han F, Kamata A, Shirasaki Y, Qin Z, et al. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities. Cardiovasc Ther. 2009;27(1):17\u201327.","journal-title":"Cardiovasc Ther"},{"key":"3594_CR17","doi-asserted-by":"crossref","unstructured":"Kumar M, Sikri N, Chahal S, Sharma J, Sharma B, Yadav P, et al. Urease inhibitory kinetic studies of various extracts and pure compounds from Cinnamomum genus. Molecules. 2021;26(13):3803.","DOI":"10.3390\/molecules26133803"},{"key":"3594_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijfoodmicro.2014.11.028","volume":"195","author":"Y Kim","year":"2015","unstructured":"Kim Y, Lee J, Kim S, Baek K, Lee J. Cinnamon bark oil and its components inhibit biofilm formation and toxin production. Int J Food Microbiol. 2015;195:30\u20139.","journal-title":"Int J Food Microbiol"},{"issue":"2","key":"3594_CR19","doi-asserted-by":"publisher","first-page":"595","DOI":"10.21873\/invivo.11812","volume":"34","author":"J Chen","year":"2020","unstructured":"Chen J, Hsieh P, Chen S, Hwang J. Effects of Cinnamaldehyde on the viability and expression of chemokine receptor genes in Temozolomide-treated Glioma cells. In Vivo. 2020;34(2):595\u20139.","journal-title":"In Vivo"},{"key":"3594_CR20","doi-asserted-by":"crossref","unstructured":"Wang R, Li S, Jia H, Si X, Lei Y, Lyu J, et al. Salmonella typhimuriumProtective effects of Cinnamaldehyde on the inflammatory response, oxidative stress, and apoptosis in liver of -challenged mice. Molecules. 2021;26(8)2309.","DOI":"10.3390\/molecules26082309"},{"key":"3594_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2020.115122","volume":"402","author":"H Afify","year":"2020","unstructured":"Afify H, Abo-Youssef A, Abdel-Rahman H, Allam S, Azouz A. The modulatory effects of cinnamaldehyde on uric acid level and IL-6\/JAK1\/STAT3 signaling as a promising therapeutic strategy against benign prostatic hyperplasia. Toxicol Appl Pharmacol. 2020;402:115122.","journal-title":"Toxicol Appl Pharmacol"},{"key":"3594_CR22","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.3389\/fmicb.2019.02241","volume":"10","author":"Z He","year":"2019","unstructured":"He Z, Huang Z, Jiang W, Zhou W. Streptococcus mutansAntimicrobial activity of Cinnamaldehyde on biofilms. Front Microbiol. 2019;10:2241.","journal-title":"Front Microbiol"},{"key":"3594_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejphar.2019.02.031","volume":"852","author":"S Mateen","year":"2019","unstructured":"Mateen S, Rehman M, Shahzad S, Naeem S, Faizy A, Khan A, et al. Anti-oxidant and anti-inflammatory effects of cinnamaldehyde and eugenol on mononuclear cells of rheumatoid arthritis patients. Eur J Pharmacol. 2019;852:14\u201324.","journal-title":"Eur J Pharmacol"},{"key":"3594_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.biopha.2017.01.054","volume":"88","author":"A Hosni","year":"2017","unstructured":"Hosni A, Abdel-Moneim A, Abdel-Reheim E, Mohamed S, Helmy H. Cinnamaldehyde potentially attenuates gestational hyperglycemia in rats through modulation of PPAR\u03b3, proinflammatory cytokines and oxidative stress. Biomed Pharmacother. 2017;88:52\u201360.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3594_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/FJC.0000000000000679","volume":"74","author":"D Wang","year":"2019","unstructured":"Wang D, Hou J, Yang Y, Zhou P, Liu S, Wan J, et al. Cinnamaldehyde ameliorates high-glucose-induced oxidative stress and Cardiomyocyte injury through transient receptor potential Ankyrin 1. J Cardiovasc Pharmacol. 2019;74(1):30\u20137.","journal-title":"J Cardiovasc Pharmacol"},{"key":"3594_CR26","doi-asserted-by":"publisher","first-page":"27460","DOI":"10.1038\/srep27460","volume":"6","author":"L Kang","year":"2016","unstructured":"Kang L, Zhang D, Ma C, Zhang J, Jia K, Liu J, et al. Cinnamaldehyde and allopurinol reduce fructose-induced cardiac inflammation and fibrosis by attenuating CD36-mediated TLR4\/6-IRAK4\/1 signaling to suppress NLRP3 inflammasome activation. Sci Rep. 2016;6:27460.","journal-title":"Sci Rep"},{"issue":"1","key":"3594_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jep.2013.08.019","volume":"150","author":"F Song","year":"2013","unstructured":"Song F, Li H, Sun J, Wang S. Protective effects of cinnamic acid and cinnamic aldehyde on isoproterenol-induced acute myocardial ischemia in rats. J Ethnopharmacol. 2013;150(1):125\u201330.","journal-title":"J Ethnopharmacol"},{"issue":"11","key":"3594_CR28","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s00424-014-1472-8","volume":"466","author":"J Alvarez-Collazo","year":"2014","unstructured":"Alvarez-Collazo J, Alonso-Carbajo L, L\u00f3pez-Medina A, Alpizar Y, Tajada S, Nilius B, et al. Cinnamaldehyde inhibits L-type calcium channels in mouse ventricular cardiomyocytes and vascular smooth muscle cells. Pflugers Arch. 2014;466(11):2089\u201399.","journal-title":"Pflugers Arch"},{"key":"3594_CR29","first-page":"273","volume":"7","author":"Y Xue","year":"2011","unstructured":"Xue Y, Shi H, Murad F, Bian K. Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aorta. Vasc Health Risk Manag. 2011;7:273\u201380.","journal-title":"Vasc Health Risk Manag"},{"key":"3594_CR30","doi-asserted-by":"crossref","unstructured":"Harada M, Yano S. Pharmacological studies on Chinese cinnamon. II. Effects of Cinnamaldehyde on the cardiovascular and digestive systems. Chem Pharm Bull. 1975;23(5):941\u20137.","DOI":"10.1248\/cpb.23.941"},{"issue":"3","key":"3594_CR31","first-page":"72","volume":"18","author":"XU Ming","year":"2006","unstructured":"Ming XU, Lu YU, Ding YY, Wang YM, Wang SW, Pei JM. Experimental study on hypotensive effects of Cinnamaldehyde in anesthetized rats. Chinese Heart J. 2006;18(3):72\u2013276.","journal-title":"Chinese Heart J."},{"issue":"1","key":"3594_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/FJC.0b013e31829013ff","volume":"62","author":"RC Veras","year":"2013","unstructured":"Veras RC, Rodrigues KG, Alustau MDC, Ara\u00fajo IGA, de Barros ALB, Alves RJ, et al. Participation of nitric oxide pathway in the relaxation response induced by E-cynnamaldehyde-oxime in superior mesenteric artery isolated from rats. J Cardiovasc Pharmacol. 2013;62(1):58\u201366.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"11","key":"3594_CR33","first-page":"14345","volume":"8","author":"L Yang","year":"2015","unstructured":"Yang L, Wu QQ, Yuan L, Hu ZF, Tang QZ. Cinnamaldehyde attenuates pressure overload-induced cardiac hypertrophy. Int J Clin Exp Pathol. 2015;8(11):14345\u201354.","journal-title":"Int J Clin Exp Pathol"},{"key":"3594_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.yjmcc.2016.10.017","volume":"101","author":"H Zhao","year":"2016","unstructured":"Zhao H, Zhang M, Zhou F, Cao W, Bi L, Xie Y, et al. Cinnamaldehyde ameliorates LPS-induced cardiac dysfunction via TLR4-NOX4 pathway: the regulation of autophagy and ROS production. J Mol Cell Cardiol. 2016;101:11\u201324.","journal-title":"J Mol Cell Cardiol."},{"issue":"7","key":"3594_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.196","volume":"1","author":"V Ravi","year":"2021","unstructured":"Ravi V, Jain A, Taneja A, Chatterjee K, Sundaresan N. Isolation and culture of neonatal murine primary Cardiomyocytes. Curr Protoc. 2021;1(7):e196.","journal-title":"Curr Protoc"},{"issue":"6","key":"3594_CR36","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1006\/jmcc.2000.1135","volume":"32","author":"T Ueyama","year":"2000","unstructured":"Ueyama T, Kawashima S, Sakoda T, Rikitake Y, Ishida T, Kawai M, et al. Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy. J Mol Cell Cardiol. 2000;32(6):947\u201360.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"3594_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bbrc.2018.09.065","volume":"506","author":"X Zhang","year":"2018","unstructured":"Zhang X, Zhang M, Wang C. Loss of LRRC25 accelerates pathological cardiac hypertrophy through promoting fibrosis and inflammation regulated by TGF-\u03b21. Biochem Biophys Res Commun. 2018;506(1):137\u201344.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3594_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball C, Blake J, Botstein D, Butler H, Cherry J, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25(1):25\u20139.","journal-title":"Nat Genet"},{"issue":"D1","key":"3594_CR39","doi-asserted-by":"publisher","first-page":"D325","DOI":"10.1093\/nar\/gkaa1113","volume":"49","author":"The Gene Ontology Consortium","year":"2021","unstructured":"The Gene Ontology Consortium. The gene ontology resource: enriching a GOld mine. Nucleic Acids Res. 2021;49(D1):D325\u201334.","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"3594_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/nar\/27.1.29","volume":"27","author":"H Ogata","year":"1999","unstructured":"Ogata H, Goto S, Sato K, Fujibuchi W, Kanehisa M. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999;27(1):29\u201334.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"3594_CR41","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 2019;28(11):1947\u201351.","journal-title":"Protein Sci"},{"issue":"D1","key":"3594_CR42","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"K Minoru","year":"2021","unstructured":"Minoru K, Miho F, Yoko S, Mari IW, Mao T. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 2021;49(D1):D545\u201351.","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"3594_CR43","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.yjmcc.2011.11.003","volume":"52","author":"X Luo","year":"2012","unstructured":"Luo X, Hojayev B, Jiang N, Wang Z, Tandan S, Rakalin A, et al. STIM1-dependent store-operated Ca2+ entry is required for pathological cardiac hypertrophy. J Mol Cell Cardiol. 2012;52(1):136\u201347.","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"3594_CR44","doi-asserted-by":"publisher","first-page":"C277","DOI":"10.1152\/ajpcell.00094.2016","volume":"311","author":"C Pasqualin","year":"2016","unstructured":"Pasqualin C, Gannier F, Yu A, Mal\u00e9cot C, Bredeloux P, Maupoil V. SarcOptiM for ImageJ: high-frequency online sarcomere length computing on stimulated cardiomyocytes. Am J Phys Cell Physiol. 2016;311(2):C277\u201383.","journal-title":"Am J Phys Cell Physiol"},{"issue":"2","key":"3594_CR45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/cvr\/cvv108","volume":"106","author":"L Zhong","year":"2015","unstructured":"Zhong L, Chiusa M, Cadar A, Lin A, Samaras S, Davidson J, et al. Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy. Cardiovasc Res. 2015;106(2):261\u201371.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"3594_CR46","first-page":"H202","volume":"279","author":"F Sedarat","year":"2000","unstructured":"Sedarat F, Xu L, Moore E, Tibbits G. Colocalization of dihydropyridine and ryanodine receptors in neonate rabbit heart using confocal microscopy. Am J Phys Heart Circ Phys. 2000;279(1):H202\u20139.","journal-title":"Am J Phys Heart Circ Phys"},{"issue":"25","key":"3594_CR47","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1161\/CIRCULATIONAHA.107.707257","volume":"116","author":"L Chang","year":"2007","unstructured":"Chang L, Zhang J, Tseng Y, Xie C, Ilany J, Br\u00fcning J, et al. Rad GTPase deficiency leads to cardiac hypertrophy. Circulation. 2007;116(25):2976\u201383.","journal-title":"Circulation"},{"issue":"7","key":"3594_CR48","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1073\/pnas.0813013106","volume":"106","author":"J Backs","year":"2009","unstructured":"Backs J, Backs T, Neef S, Kreusser M, Lehmann L, Patrick D, et al. The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc Natl Acad Sci U S A. 2009;106(7):2342\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3594_CR49","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jphs.2020.07.001","volume":"144","author":"J Li","year":"2020","unstructured":"Li J, Gao Q, Wang S, Kang Z, Li Z, Lei S, et al. Sustained increased CaMKII phosphorylation is involved in the impaired regression of isoproterenol-induced cardiac hypertrophy in rats. J Pharmacol Sci. 2020;144(1):30\u201342.","journal-title":"J Pharmacol Sci"},{"issue":"3","key":"3594_CR50","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2008.02.048","volume":"133","author":"J Erickson","year":"2008","unstructured":"Erickson J, Joiner M, Guan X, Kutschke W, Yang J, Oddis C, et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell. 2008;133(3):462\u201374.","journal-title":"Cell"},{"issue":"42","key":"3594_CR51","doi-asserted-by":"publisher","first-page":"25646","DOI":"10.1074\/jbc.M115.650234","volume":"290","author":"J Erickson","year":"2015","unstructured":"Erickson J, Nichols C, Uchinoumi H, Stein M, Bossuyt J, Bers D. S-Nitrosylation induces both autonomous activation and inhibition of calcium\/Calmodulin-dependent protein kinase II \u03b4. J Biol Chem. 2015;290(42):25646\u201356.","journal-title":"J Biol Chem"},{"issue":"7471","key":"3594_CR52","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nature12537","volume":"502","author":"J Erickson","year":"2013","unstructured":"Erickson J, Pereira L, Wang L, Han G, Ferguson A, Dao K, et al. Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation. Nature. 2013;502(7471):372\u20136.","journal-title":"Nature"},{"issue":"48","key":"3594_CR53","doi-asserted-by":"publisher","first-page":"37895","DOI":"10.1074\/jbc.M007037200","volume":"275","author":"T Yue","year":"2000","unstructured":"Yue T, Gu J, Wang C, Reith A, Lee J, Mirabile R, et al. Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy. J Biol Chem. 2000;275(48):37895\u2013901.","journal-title":"J Biol Chem"},{"issue":"12","key":"3594_CR54","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.1073\/pnas.111155798","volume":"98","author":"N Purcell","year":"2001","unstructured":"Purcell N, Tang G, Yu C, Mercurio F, DiDonato J, Lin A. Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci U S A. 2001;98(12):6668\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3594_CR55","doi-asserted-by":"publisher","first-page":"8684014","DOI":"10.1155\/2022\/8684014","volume":"2022","author":"P Liu","year":"2022","unstructured":"Liu P, Pan Q. Butein inhibits oxidative stress injury in rats with chronic heart failure via ERK\/Nrf2 signaling. Cardiovasc Ther. 2022;2022:8684014.","journal-title":"Cardiovasc Ther"},{"issue":"1","key":"3594_CR56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1050-1738(00)00039-6","volume":"10","author":"J Han","year":"2000","unstructured":"Han J, Molkentin J. Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology. Trends Cardiovasc Med. 2000;10(1):19\u201322.","journal-title":"Trends Cardiovasc Med"},{"key":"3594_CR57","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1042\/bj20021395","volume":"371","author":"A Barron","year":"2003","unstructured":"Barron A, Finn S, Fuller S. Chronic activation of extracellular-signal-regulated protein kinases by phenylephrine is required to elicit a hypertrophic response in cardiac myocytes. Biochem J. 2003;371:71\u20139.","journal-title":"Biochem J"},{"key":"3594_CR58","doi-asserted-by":"crossref","unstructured":"Pavez-Giani M, S\u00e1nchez-Aguilera P, Bomer N, Miyamoto S, Booij H, Giraldo P, et al. ATPase inhibitory factor-1 disrupts mitochondrial Ca handling and promotes pathological cardiac hypertrophy through CaMKII\u03b4. Int J Mol Sci. 2021;22(9):4427.","DOI":"10.3390\/ijms22094427"},{"key":"3594_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.668129","volume":"8","author":"Y Yang","year":"2021","unstructured":"Yang Y, Jiang K, Liu X, Qin M, Xiang Y. CaMKII in regulation of cell death during myocardial reperfusion injury. Front Mol Biosci. 2021;8:668129.","journal-title":"Front Mol Biosci"},{"issue":"6","key":"3594_CR60","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1161\/CIRCRESAHA.109.203836","volume":"106","author":"S Neef","year":"2010","unstructured":"Neef S, Dybkova N, Sossalla S, Ort K, Fluschnik N, Neumann K, et al. CaMKII-dependent diastolic SR Ca2+ leak and elevated diastolic Ca2+ levels in right atrial myocardium of patients with atrial fibrillation. Circ Res. 2010;106(6):1134\u201344.","journal-title":"Circ Res"},{"issue":"25","key":"3594_CR61","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1161\/CIRCULATIONAHA.110.982298","volume":"122","author":"R van Oort","year":"2010","unstructured":"van Oort R, McCauley M, Dixit S, Pereira L, Yang Y, Respress J, et al. Ryanodine receptor phosphorylation by calcium\/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure. Circulation. 2010;122(25):2669\u201379.","journal-title":"Circulation"},{"issue":"7","key":"3594_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey M, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410.","journal-title":"PLoS Biol"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-022-03594-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-022-03594-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-022-03594-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T14:04:24Z","timestamp":1650895464000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-022-03594-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3594"],"URL":"https:\/\/doi.org\/10.1186\/s12906-022-03594-1","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"assertion":[{"value":"31 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental protocol was approved by the Animal Use Committees of Shanghai University of Traditional Chinese Medicine which in compliance with both the laboratory animal-guidelines for ethical review of animal welfare, the National Standard of People\u2019s Republic of China (GB\/T 35892\u20132018) and the guidelines 2.0 of the ARRIVE [].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}